Cedryl acetate(Cat No.:I018200) is a tricyclic sesquiterpene compound obtained from the plant Psidium caudatum. This natural compound exhibits α-glucosidase inhibitory activity. α-glucosidase is an enzyme involved in the breakdown of complex carbohydrates into simple sugars. By inhibiting this enzyme, central acetate can slow down the digestion and absorption of carbohydrates, leading to reduced postprandial glucose levels. The α-glucosidase inhibitory activity of central acetate suggests its potential use in managing conditions like diabetes and controlling blood glucose levels.
Catalog Number | I018200 |
CAS Number | 77-54-3 |
Molecular Formula | C₁₇H₂₈O₂ |
Purity | ≥95% |
Storage | 2-8°C |
IUPAC Name | [(1S,2R,5S,7R,8R)-2,6,6,8-tetramethyl-8-tricyclo[5.3.1.01,5]undecanyl] acetate |
InChI | InChI=1S/C17H28O2/c1-11-6-7-13-15(3,4)14-10-17(11,13)9-8-16(14,5)19-12(2)18/h11,13-14H,6-10H2,1-5H3/t11-,13+,14-,16-,17+/m1/s1 |
InChIKey | HQKQRXZEXPXXIG-DTWJZALFSA-N |
SMILES | CC1CCC2C13CCC(C(C3)C2(C)C)(C)OC(=O)C |
Reference | [1]. Sultan S, et al. Fungal transformation of cedryl acetate and α-glucosidase inhibition assay, quantum mechanical calculations and molecular docking studies of its metabolites. Eur J Med Chem. 2013 Apr;62:764-70. |